Our study also found that there was no significant increase in prevalence of KRAS among Puerto Rican Hispanic as opposed to non-Hispanic AML patients in the Bradley cohort (4.91% vs. 4.3%; p = 1), although Puerto Rican Hispanic AML patients have a significantly higher KRAS mutation frequency than Hispanic AML patients in the Bradley cohort. Here, KRAS is linked to acute myeloid leukemia.